scholarly journals Enhancement of transforming growth factor-α synthesis in multicellular tumour spheroids of A431 squamous carcinoma cells

1992 ◽  
Vol 65 (2) ◽  
pp. 157-162 ◽  
Author(s):  
KR Laderoute ◽  
BJ Murphy ◽  
SM Short ◽  
TD Grant ◽  
AM Knapp ◽  
...  
Keyword(s):  
Growth Factor ◽  
Transforming Growth Factor ◽  
Squamous Carcinoma ◽  
Carcinoma Cells ◽  
Transforming Growth Factor Α ◽  
Squamous Carcinoma Cells ◽  
Tumour Spheroids ◽  
Factor Α

scholarly journals Radiation-induced Release of Transforming Growth Factor α Activates the Epidermal Growth Factor Receptor and Mitogen-activated Protein Kinase Pathway in Carcinoma Cells, Leading to Increased Proliferation and Protection from Radiation-induced Cell Death

1999 ◽  
Vol 10 (8) ◽  
pp. 2493-2506 ◽  
Author(s):  
Paul Dent ◽  
Dean B. Reardon ◽  
Jong Sung Park ◽  
Geoffrey Bowers ◽  
Craig Logsdon ◽  
...  
Keyword(s):  
Growth Factor ◽  
Transforming Growth Factor ◽  
Carcinoma Cells ◽  
Mitogen Activated Protein Kinase ◽  
Jnk Pathway ◽  
Transforming Growth Factor Α ◽  
Radiation Induced ◽  
Factor Α ◽  
Primary Activation ◽  
Secondary Activation

Exposure of A431 squamous and MDA-MB-231 mammary carcinoma cells to ionizing radiation has been associated with short transient increases in epidermal growth factor receptor (EGFR) tyrosine phosphorylation and activation of the mitogen-activated protein kinase (MAPK) and c-Jun NH2-terminal kinase (JNK) pathways. Irradiation (2 Gy) of A431 and MDA-MB-231 cells caused immediate primary activations (0–10 min) of the EGFR and the MAPK and JNK pathways, which were surprisingly followed by later prolonged secondary activations (90–240 min). Primary and secondary activation of the EGFR was abolished by molecular inhibition of EGFR function. The primary and secondary activation of the MAPK pathway was abolished by molecular inhibition of either EGFR or Ras function. In contrast, molecular inhibition of EGFR function abolished the secondary but not the primary activation of the JNK pathway. Inhibition of tumor necrosis factor α receptor function by use of neutralizing monoclonal antibodies blunted primary activation of the JNK pathway. Addition of a neutralizing monoclonal antibody versus transforming growth factor α (TGFα) had no effect on the primary activation of either the EGFR or the MAPK and JNK pathways after irradiation but abolished the secondary activation of EGFR, MAPK, and JNK. Irradiation of cells increased pro-TGFα cleavage 120–180 min after exposure. In agreement with radiation-induced release of a soluble factor, activation of the EGFR and the MAPK and JNK pathways could be induced in nonirradiated cells by the transfer of media from irradiated cells 120 min after irradiation. The ability of the transferred media to cause MAPK and JNK activation was blocked when media were incubated with a neutralizing antibody to TGFα. Thus radiation causes primary and secondary activation of the EGFR and the MAPK and JNK pathways in autocrine-regulated carcinoma cells. Secondary activation of the EGFR and the MAPK and JNK pathways is dependent on radiation-induced cleavage and autocrine action of TGFα. Neutralization of TGFα function by an anti-TGFα antibody or inhibition of MAPK function by MEK1/2 inhibitors (PD98059 and U0126) radiosensitized A431 and MDA-MB-231 cells after irradiation in apoptosis, 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT), and clonogenic assays. These data demonstrate that disruption of the TGFα–EGFR–MAPK signaling module represents a strategy to decrease carcinoma cell growth and survival after irradiation.

Sign in / Sign up

Export Citation Format

Share Document